Literature DB >> 16045527

Thermal ablation performed in a primary care setting: the South Warwickshire Experience.

Karl S Oláh1, Joanne Alliston, Julia Jones, Gavin Stewart, Ruth Mavrommatis.   

Abstract

OBJECTIVE: To assess the feasibility of performing outpatient thermal ablation in a primary care setting.
DESIGN: Prospective study.
SETTING: A small peripheral hospital in the UK used by local general practitioners and visiting hospital practitioners for its outpatient facilities. POPULATION: The area of South Warwickshire serves a population of 270,000.
METHODS: Two general practitioners were trained to perform outpatient thermal ablation using the Thermachoice thermal ablation system (Thermachoice II). The unit functioned autonomously with support from a local gynaecologist and radiologist, accepting referrals from hospital consultants and general practitioners. MAIN OUTCOME MEASURES: Severity of menstrual loss, premenstrual symptoms, dysmenorrhoea and quality of life assessed by visual analogue scales before treatment and at one month, two months, one year and two years.
RESULTS: Eighty-seven women were treated. No major complications were encountered from the procedure. Reduction of menstrual loss or cure was reported by over 94% of women. Premenstrual syndrome (PMS) and symptoms of dysmenorrhoea were also improved by treatment. The majority of women were satisfied with the operation at one month (96%), two months (93%), one year (92%) and two years (94%).
CONCLUSIONS: Thermal ablation is a simple procedure well suited to an outpatient setting. There are few complications as a result of the use of the thermal ablation catheters, and this study has shown that the procedure can be undertaken in a primary care setting with excellent results.

Entities:  

Mesh:

Year:  2005        PMID: 16045527     DOI: 10.1111/j.1471-0528.2005.00635.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  1 in total

1.  Outpatient Thermachoice endometrial balloon ablation: long-term, prognostic and quality-of-life measures.

Authors:  Rajesh Varma; Hemi Soneja; Nadia Samuel; Eki Sangha; Thomas Justin Clark; Janesh K Gupta
Journal:  Gynecol Obstet Invest       Date:  2010-06-16       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.